- Temsirolimus and rituximab in patients with relapsed or refractory mantle cell lymphoma: a phase 2 study. Ansell, S.M., Tang, H., Kurtin, P.J., Koenig, P.A., Inwards, D.J., Shah, K., Ziesmer, S.C., Feldman, A.L., Rao, R., Gupta, M., Erlichman, C., Witzig, T.E. Lancet Oncol. (2011)